Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program
Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background
Integrating a Polygenic Risk Score for Coronary Artery Disease as a RiskEnhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study
Precision Medicine in Cardiovascular Disease Prevention: Clinical Validation of Multi-Ancestry Polygenic Risk Scores in a U.S. Cohort
Development and Validation of a Polygenic Risk Score for Coronary Artery Disease
Genetic assessments of breast cancer risk that do not account for polygenic background are incomplete and lead to incorrect preventative strategies